Video Experimental Relacionado
Updated: May 5, 2026
08:22
Reverse Genetic Morpholino Approach Using Cardiac Ventricular Injection to Transfect Multiple Difficult-to-target Tissues in the Zebrafish Larva
Published on: June 17, 2014
10.3K
La reptina y la pontina regulan antagónicamente el crecimiento del corazón en los embriones de pez cebra
Wolfgang Rottbauer1, Andrew J Saurin, Heiko Lickert
1Cardiovascular Research Center, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, MA 02114, USA.
Cell
|December 5, 2002
Resumen
Una mutación en el pez cebra causa el agrandamiento del corazón embrionario mediante la sobreactivación de la Reptina, un componente del complejo proteico. Esto sugiere que la relación Reptin/Pontin regula el crecimiento del corazón a través de la vía de la beta-catenina.
Área de la Ciencia:
- Biología del desarrollo Biología del desarrollo.
- Investigaciones Cardiovasculares Investigación Cardiovascular Investigaciones Cardiovasculares
- Genética La genética.
Sus antecedentes:
- La regulación del tamaño de los órganos es crucial pero poco comprendida.
- El desarrollo del corazón embrionario implica un control preciso de la proliferación celular.
Objetivo del estudio:
- Para investigar los mecanismos genéticos que controlan el tamaño del corazón embrionario del pez cebra.
- Para identificar genes y vías involucradas en la hiperplasia cardíaca.
Principales métodos:
- Aislamiento y caracterización de la mutación del pez cebra "liebeskummer" (lik).
- Análisis de la función de la proteína Reptin y la actividad de la ATPasa.
- Investigando el papel de la beta-catenina y la pontina en el desarrollo cardíaco.
Principales resultados:
- La mutación lik en el pez cebra conduce a corazones embrionarios hiperplásticos.
- La mutación aumenta la actividad de la ATPasa de los complejos de Reptin, causando la proliferación de los cardiomiocitos.
- La relación Reptin/Pontin y la vía beta-catenina son críticas para la regulación del crecimiento del corazón.
Conclusiones:
- La relación Reptin/Pontin es un regulador clave del crecimiento del corazón embrionario.
- La desregulación de esta relación, como se ve en la mutación de lik, da lugar a hiperplasia cardíaca.
- Los hallazgos implican la vía de la beta-catenina en el desarrollo cardíaco mediado por Reptin/Pontin.
Videos de Conceptos Relacionados
01:30Combined Effects of Drugs: Antagonism
11.8K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.8K
01:17Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
01:22Heart Failure Drugs: β-Blockers
2.9K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.9K